Advancement of therapeutic antibody discovery faces time and economic constraints. Merck R&D experts address this issue using Sphere Bio's microfluidic picodroplet technology. Fast, high-throughput ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results